In the management of hypertensive acute glomerulonephritis, which medication would be added to hydralazine?

In the management of hypertensive acute glomerulonephritis, the addition of furosemide is a key component of treatment. Furosemide is a loop diuretic that helps to reduce fluid overload by promoting diuresis, thereby decreasing blood volume and, as a result, lowering blood pressure. This is particularly important in cases of acute glomerulonephritis where patients may experience significant fluid retention and hypertension due to renal impairment, inflammatory processes, or increased circulating volume from various etiologies.

Hydralazine, a vasodilator, works to decrease systemic vascular resistance and therefore lowers blood pressure. However, without adequate control of volume status and a means to reduce excess fluid, patients may still have persistent hypertension or heart failure exacerbations. By adding furosemide, not only is blood pressure managed more effectively, but it also addresses the complications associated with fluid overload.

Other medications listed, such as digoxin, alprazolam, and phenytoin, do not have a direct or primary role in managing the hypertensive state or fluid balance associated with acute glomerulonephritis. Digoxin is primarily used for heart failure and atrial fibrillation, alprazolam is an anxiolytic